The gut microbial metabolite, 3,4-dihydroxyphenylpropionic acid, alleviates hepatic ischemia/reperfusion injury via mitigation of macrophage pro-inflammatory activity in mice
Authors:
Open Access
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 12 (1) , 182-196
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Protective Role of Hepatocyte Cyclooxygenase‐2 Expression Against Liver Ischemia–Reperfusion Injury in MiceHepatology, 2019
- SIRT3 a Major Player in Attenuation of Hepatic Ischemia‐Reperfusion Injury by Reducing ROS via Its Downstream Mediators: SOD2, CYP‐D, and HIF‐1αOxidative Medicine and Cellular Longevity, 2018
- Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injuryJournal of Hepatology, 2017
- Hepatic Ischemia/Reperfusion: Mechanisms of Tissue Injury, Repair, and RegenerationGene Expression, 2017
- The myeloid heat shock transcription factor 1/β‐catenin axis regulates NLR family, pyrin domain‐containing 3 inflammasome activation in mouse liver ischemia/reperfusion injuryHepatology, 2016
- Fatty acid binding protein-4 (FABP4) is a hypoxia inducible gene that sensitizes mice to liver ischemia/reperfusion injuryJournal of Hepatology, 2015
- T‐cell immunoglobulin and mucin domain 4 (TIM‐4) signaling in innate immune‐mediated liver ischemia‐reperfusion injuryHepatology, 2014
- Long-Term Patient Outcome and Quality of Life After Liver TransplantationAnnals of Surgery, 2010
- Molecular Mediators of Liver Ischemia and Reperfusion Injury: A Brief ReviewMolecular Medicine, 2008
- Past and future approaches to ischemia-reperfusion lesion associated with liver transplantationLife Sciences, 2006